Last 12 months
Inside the activity.
0 purchase rows · 0 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| September 12, 2017 Filed Sep 14, 2017 17:39 UTC |
Aklog LishanDirector · Chairman and CEO · 10% owner
HCFP/Capital Partners III LLC10% owner
Pavilion Venture Partners LLC10% owner
|
PurchaseWarrants · Derivative | 200 | Not disclosed Strike: $5.00 | Not disclosed |
DisclosureSEC source: 0001094891-17-000236 · edgar.xml · derivative · entry 11 Aklog Lishan · CIK 0001665074 · Director · Chairman and CEO · 10% owner HCFP/Capital Partners III LLC · CIK 0001665111 · 10% owner Pavilion Venture Partners LLC · CIK 0001665114 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,300 Underlying: Common Stock · 200 shares Expires 2022-01-29 F3 · price: The warrants were purchased at a weighted average price of approximately $2.71 per warrant. These warrants were purchased in multiple transactions at prices ranging from $2.10 to $3.32, inclusive. The reporting person undertakes to provide PAVmed Inc., any security holder of PAVmed Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of warrants purchased at each separate price within the ranges set forth this footnote to this Form 4. Read SEC document |
| September 12, 2017 Filed Sep 14, 2017 17:39 UTC |
Aklog LishanDirector · Chairman and CEO · 10% owner
HCFP/Capital Partners III LLC10% owner
Pavilion Venture Partners LLC10% owner
|
PurchaseCommon Stock | 100 | $6.66 | $666.00 |
DisclosureSEC source: 0001094891-17-000236 · edgar.xml · nonDerivative · entry 2 Aklog Lishan · CIK 0001665074 · Director · Chairman and CEO · 10% owner HCFP/Capital Partners III LLC · CIK 0001665111 · 10% owner Pavilion Venture Partners LLC · CIK 0001665114 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 65,838 Read SEC document |
| September 11, 2017 Filed Sep 14, 2017 17:39 UTC |
Aklog LishanDirector · Chairman and CEO · 10% owner
HCFP/Capital Partners III LLC10% owner
Pavilion Venture Partners LLC10% owner
|
PurchaseCommon Stock | 300 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001094891-17-000236 · edgar.xml · nonDerivative · entry 1 Aklog Lishan · CIK 0001665074 · Director · Chairman and CEO · 10% owner HCFP/Capital Partners III LLC · CIK 0001665111 · 10% owner Pavilion Venture Partners LLC · CIK 0001665114 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 65,738 F1 · price: The shares were purchased at a weighted average price of approximately $6.383 per share. These shares were purchased in multiple transactions at prices ranging from $6.35 to $6.45, inclusive. The reporting person undertakes to provide to PAVmed Inc., any security holder of PAVmed Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth this footnote to this Form 4. Read SEC document |
| September 08, 2017 Filed Sep 11, 2017 11:21 UTC |
Aklog LishanDirector · Chairman and CEO · 10% owner
HCFP/Capital Partners III LLC10% owner
Pavilion Venture Partners LLC10% owner
|
PurchaseWarrants · Derivative | 300 | Not disclosed Strike: $5.00 | Not disclosed |
DisclosureSEC source: 0001094891-17-000234 · edgar.xml · derivative · entry 11 Aklog Lishan · CIK 0001665074 · Director · Chairman and CEO · 10% owner HCFP/Capital Partners III LLC · CIK 0001665111 · 10% owner Pavilion Venture Partners LLC · CIK 0001665114 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,100 Underlying: Common Stock · 300 shares Expires 2022-01-29 F3 · price: The warrants were purchased at a weighted average price of approximately $1.3167per warrant. These warrants were purchased in multiple transactions at prices ranging from $1.15 to $1.45, inclusive. The reporting person undertakes to provide PAVmed Inc., any security holder of PAVmed Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of warrants purchased at each separate price within the ranges set forth this footnote to this Form 4. Read SEC document |
| September 08, 2017 Filed Sep 11, 2017 11:21 UTC |
Aklog LishanDirector · Chairman and CEO · 10% owner
HCFP/Capital Partners III LLC10% owner
Pavilion Venture Partners LLC10% owner
|
PurchaseCommon Stock | 400 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001094891-17-000234 · edgar.xml · nonDerivative · entry 2 Aklog Lishan · CIK 0001665074 · Director · Chairman and CEO · 10% owner HCFP/Capital Partners III LLC · CIK 0001665111 · 10% owner Pavilion Venture Partners LLC · CIK 0001665114 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 65,438 F2 · price: The shares were purchased at a weighted average price of approximately $5.98 per share. These shares were purchased in multiple transactions at prices ranging from $5.73 to $6.25, inclusive. The reporting person undertakes to provide to PAVmed Inc., any security holder of PAVmed Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth this footnote to this Form 4. Read SEC document |
| September 07, 2017 Filed Sep 11, 2017 11:21 UTC |
Aklog LishanDirector · Chairman and CEO · 10% owner
HCFP/Capital Partners III LLC10% owner
Pavilion Venture Partners LLC10% owner
|
PurchaseWarrants · Derivative | 200 | $1.20 Strike: $5.00 | $240.00 |
DisclosureSEC source: 0001094891-17-000234 · edgar.xml · derivative · entry 10 Aklog Lishan · CIK 0001665074 · Director · Chairman and CEO · 10% owner HCFP/Capital Partners III LLC · CIK 0001665111 · 10% owner Pavilion Venture Partners LLC · CIK 0001665114 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 49,800 Underlying: Common Stock · 200 shares Expires 2022-01-29 Read SEC document |
| September 07, 2017 Filed Sep 11, 2017 11:21 UTC |
Aklog LishanDirector · Chairman and CEO · 10% owner
HCFP/Capital Partners III LLC10% owner
Pavilion Venture Partners LLC10% owner
|
PurchaseCommon Stock | 850 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001094891-17-000234 · edgar.xml · nonDerivative · entry 1 Aklog Lishan · CIK 0001665074 · Director · Chairman and CEO · 10% owner HCFP/Capital Partners III LLC · CIK 0001665111 · 10% owner Pavilion Venture Partners LLC · CIK 0001665114 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 65,038 F1 · price: The shares were purchased at a weighted average price of approximately $5.11297047 per share. These shares were purchased in multiple transactions at prices ranging from $4.74 to $5.95, inclusive. The reporting person undertakes to provide to PAVmed Inc., any security holder of PAVmed Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth this footnote to this Form 4. Read SEC document |
| September 06, 2017 Filed Sep 7, 2017 17:46 UTC |
Aklog LishanDirector · Chairman and CEO · 10% owner
HCFP/Capital Partners III LLC10% owner
Pavilion Venture Partners LLC10% owner
|
PurchaseWarrants · Derivative | 800 | Not disclosed Strike: $5.00 | Not disclosed |
DisclosureSEC source: 0001094891-17-000229 · edgar.xml · derivative · entry 12 Aklog Lishan · CIK 0001665074 · Director · Chairman and CEO · 10% owner HCFP/Capital Partners III LLC · CIK 0001665111 · 10% owner Pavilion Venture Partners LLC · CIK 0001665114 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 49,600 Underlying: Common Stock · 800 shares Expires 2022-01-29 F3 · price: The warrants were purchased at a weighted average price of approximately $1.20625 per warrant. These warrants were purchased in multiple transactions at prices ranging from $1.15 to $1.35, inclusive. The reporting person undertakes to provide PAVmed Inc., any security holder of PAVmed Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of warrants purchased at each separate price within the ranges set forth this footnote to this Form 4. Read SEC document |
| September 06, 2017 Filed Sep 7, 2017 17:46 UTC |
Aklog LishanDirector · Chairman and CEO · 10% owner
HCFP/Capital Partners III LLC10% owner
Pavilion Venture Partners LLC10% owner
|
PurchaseCommon Stock | 899 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001094891-17-000229 · edgar.xml · nonDerivative · entry 2 Aklog Lishan · CIK 0001665074 · Director · Chairman and CEO · 10% owner HCFP/Capital Partners III LLC · CIK 0001665111 · 10% owner Pavilion Venture Partners LLC · CIK 0001665114 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 64,188 F2 · price: The shares were purchased at a weighted average price of approximately $4.8544493882 per share. These shares were purchased in multiple transactions at prices ranging from $4.75 to $4.99, inclusive. The reporting person undertakes to provide to PAVmed Inc., any security holder of PAVmed Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth this footnote to this Form 4. Read SEC document |
| September 05, 2017 Filed Sep 7, 2017 17:46 UTC |
Aklog LishanDirector · Chairman and CEO · 10% owner
HCFP/Capital Partners III LLC10% owner
Pavilion Venture Partners LLC10% owner
|
PurchaseWarrants · Derivative | 100 | $1.00 Strike: $5.00 | $100.00 |
DisclosureSEC source: 0001094891-17-000229 · edgar.xml · derivative · entry 11 Aklog Lishan · CIK 0001665074 · Director · Chairman and CEO · 10% owner HCFP/Capital Partners III LLC · CIK 0001665111 · 10% owner Pavilion Venture Partners LLC · CIK 0001665114 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 48,800 Underlying: Common Stock · 100 shares Expires 2022-01-29 Read SEC document |
| September 05, 2017 Filed Sep 7, 2017 17:46 UTC |
Aklog LishanDirector · Chairman and CEO · 10% owner
HCFP/Capital Partners III LLC10% owner
Pavilion Venture Partners LLC10% owner
|
PurchaseWarrants · Derivative | 100 | $0.98 Strike: $5.00 | $98.00 |
DisclosureSEC source: 0001094891-17-000229 · edgar.xml · derivative · entry 10 Aklog Lishan · CIK 0001665074 · Director · Chairman and CEO · 10% owner HCFP/Capital Partners III LLC · CIK 0001665111 · 10% owner Pavilion Venture Partners LLC · CIK 0001665114 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 48,700 Underlying: Common Stock · 100 shares Expires 2022-01-29 Read SEC document |
| September 05, 2017 Filed Sep 7, 2017 17:46 UTC |
Aklog LishanDirector · Chairman and CEO · 10% owner
HCFP/Capital Partners III LLC10% owner
Pavilion Venture Partners LLC10% owner
|
PurchaseCommon Stock | 800 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001094891-17-000229 · edgar.xml · nonDerivative · entry 1 Aklog Lishan · CIK 0001665074 · Director · Chairman and CEO · 10% owner HCFP/Capital Partners III LLC · CIK 0001665111 · 10% owner Pavilion Venture Partners LLC · CIK 0001665114 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 63,289 F1 · price: The shares were purchased at a weighted average price of approximately $4.73875 per share. These shares were purchased in multiple transactions at prices ranging from $4.50 to $4.99, inclusive. The reporting person undertakes to provide to PAVmed Inc., any security holder of PAVmed Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth this footnote to this Form 4. Read SEC document |
| September 01, 2017 Filed Sep 5, 2017 11:53 UTC |
Aklog LishanDirector · Chairman and CEO · 10% owner
HCFP/Capital Partners III LLC10% owner
Pavilion Venture Partners LLC10% owner
|
PurchaseWarrants · Derivative | 200 | Not disclosed Strike: $5.00 | Not disclosed |
DisclosureSEC source: 0001094891-17-000227 · edgar.xml · derivative · entry 15 Aklog Lishan · CIK 0001665074 · Director · Chairman and CEO · 10% owner HCFP/Capital Partners III LLC · CIK 0001665111 · 10% owner Pavilion Venture Partners LLC · CIK 0001665114 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 48,600 Underlying: Common Stock · 200 shares Expires 2022-01-29 F7 · price: The warrants were purchased at a weighted average price of approximately $1.19 per warrant. These warrants were purchased in multiple transactions at prices ranging from $1.18 to $1.20, inclusive. The reporting person undertakes to provide PAVmed Inc., any security holder of PAVmed Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of warrants purchased at each separate price within the ranges set forth this footnote to this Form 4. Read SEC document |
| September 01, 2017 Filed Sep 5, 2017 11:53 UTC |
Aklog LishanDirector · Chairman and CEO · 10% owner
HCFP/Capital Partners III LLC10% owner
Pavilion Venture Partners LLC10% owner
|
PurchaseCommon Stock | 300 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001094891-17-000227 · edgar.xml · nonDerivative · entry 4 Aklog Lishan · CIK 0001665074 · Director · Chairman and CEO · 10% owner HCFP/Capital Partners III LLC · CIK 0001665111 · 10% owner Pavilion Venture Partners LLC · CIK 0001665114 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 62,489 F4 · price: The shares were purchased at a weighted average price of approximately $4.45666667 per share. These shares were purchased in multiple transactions at prices ranging from $4.39 to $4.50, inclusive. The reporting person undertakes to provide to PAVmed Inc., any security holder of PAVmed Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth this footnote to this Form 4. Read SEC document |
| August 31, 2017 Filed Sep 5, 2017 11:53 UTC |
Aklog LishanDirector · Chairman and CEO · 10% owner
HCFP/Capital Partners III LLC10% owner
Pavilion Venture Partners LLC10% owner
|
PurchaseWarrants · Derivative | 1,700 | Not disclosed Strike: $5.00 | Not disclosed |
DisclosureSEC source: 0001094891-17-000227 · edgar.xml · derivative · entry 14 Aklog Lishan · CIK 0001665074 · Director · Chairman and CEO · 10% owner HCFP/Capital Partners III LLC · CIK 0001665111 · 10% owner Pavilion Venture Partners LLC · CIK 0001665114 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 48,400 Underlying: Common Stock · 1,700 shares Expires 2022-01-29 F6 · price: The warrants were purchased at a weighted average price of approximately $1.0375 per warrant. These warrants were purchased in multiple transactions at prices ranging from $1.01 to $1.09, inclusive. The reporting person undertakes to provide PAVmed Inc., any security holder of PAVmed Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of warrants purchased at each separate price within the ranges set forth this footnote to this Form 4. Read SEC document |
| August 31, 2017 Filed Sep 5, 2017 11:53 UTC |
Aklog LishanDirector · Chairman and CEO · 10% owner
HCFP/Capital Partners III LLC10% owner
Pavilion Venture Partners LLC10% owner
|
PurchaseCommon Stock | 1,600 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001094891-17-000227 · edgar.xml · nonDerivative · entry 3 Aklog Lishan · CIK 0001665074 · Director · Chairman and CEO · 10% owner HCFP/Capital Partners III LLC · CIK 0001665111 · 10% owner Pavilion Venture Partners LLC · CIK 0001665114 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 62,189 F3 · price: The shares were purchased at a weighted average price of approximately $4.2725 per share. These shares were purchased in multiple transactions at prices ranging from $4.20 to $4.40, inclusive. The reporting person undertakes to provide to PAVmed Inc., any security holder of PAVmed Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth this footnote to this Form 4. Read SEC document |
| August 30, 2017 Filed Sep 5, 2017 11:53 UTC |
Aklog LishanDirector · Chairman and CEO · 10% owner
HCFP/Capital Partners III LLC10% owner
Pavilion Venture Partners LLC10% owner
|
PurchaseWarrants · Derivative | 200 | $1.22 Strike: $5.00 | $244.00 |
DisclosureSEC source: 0001094891-17-000227 · edgar.xml · derivative · entry 13 Aklog Lishan · CIK 0001665074 · Director · Chairman and CEO · 10% owner HCFP/Capital Partners III LLC · CIK 0001665111 · 10% owner Pavilion Venture Partners LLC · CIK 0001665114 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 46,700 Underlying: Common Stock · 200 shares Expires 2022-01-29 Read SEC document |
| August 30, 2017 Filed Sep 5, 2017 11:53 UTC |
Aklog LishanDirector · Chairman and CEO · 10% owner
HCFP/Capital Partners III LLC10% owner
Pavilion Venture Partners LLC10% owner
|
PurchaseCommon Stock | 300 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001094891-17-000227 · edgar.xml · nonDerivative · entry 2 Aklog Lishan · CIK 0001665074 · Director · Chairman and CEO · 10% owner HCFP/Capital Partners III LLC · CIK 0001665111 · 10% owner Pavilion Venture Partners LLC · CIK 0001665114 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 60,589 F2 · price: The shares were purchased at a weighted average price of approximately $4.19666667 per share. These shares were purchased in multiple transactions at prices ranging from $4.19 to $4.20, inclusive. The reporting person undertakes to provide to PAVmed Inc., any security holder of PAVmed Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth this footnote to this Form 4. Read SEC document |
| August 29, 2017 Filed Sep 5, 2017 11:53 UTC |
Aklog LishanDirector · Chairman and CEO · 10% owner
HCFP/Capital Partners III LLC10% owner
Pavilion Venture Partners LLC10% owner
|
PurchaseWarrants · Derivative | 1,200 | Not disclosed Strike: $5.00 | Not disclosed |
DisclosureSEC source: 0001094891-17-000227 · edgar.xml · derivative · entry 12 Aklog Lishan · CIK 0001665074 · Director · Chairman and CEO · 10% owner HCFP/Capital Partners III LLC · CIK 0001665111 · 10% owner Pavilion Venture Partners LLC · CIK 0001665114 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 46,500 Underlying: Common Stock · 1,200 shares Expires 2022-01-29 F5 · price: The warrants were purchased at a weighted average price of approximately $1.4875 per warrant. These warrants were purchased in multiple transactions at prices ranging from $1.18 to $2.24, inclusive. The reporting person undertakes to provide PAVmed Inc., any security holder of PAVmed Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of warrants purchased at each separate price within the ranges set forth this footnote to this Form 4. Read SEC document |
| August 29, 2017 Filed Sep 5, 2017 11:53 UTC |
Aklog LishanDirector · Chairman and CEO · 10% owner
HCFP/Capital Partners III LLC10% owner
Pavilion Venture Partners LLC10% owner
|
PurchaseCommon Stock | 1,412 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001094891-17-000227 · edgar.xml · nonDerivative · entry 1 Aklog Lishan · CIK 0001665074 · Director · Chairman and CEO · 10% owner HCFP/Capital Partners III LLC · CIK 0001665111 · 10% owner Pavilion Venture Partners LLC · CIK 0001665114 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 60,289 F1 · price: The shares were purchased at a weighted average price of approximately $4.19770538 per share. These shares were purchased in multiple transactions at prices ranging from $4.18 to $4.20, inclusive. The reporting person undertakes to provide to PAVmed Inc., any security holder of PAVmed Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth this footnote to this Form 4. Read SEC document |
| August 25, 2017 Filed Aug 29, 2017 22:34 UTC |
Aklog LishanDirector · Chairman and CEO · 10% owner
HCFP/Capital Partners III LLC10% owner
Pavilion Venture Partners LLC10% owner
|
PurchaseWarrants · Derivative | 600 | Not disclosed Strike: $5.00 | Not disclosed |
DisclosureSEC source: 0001094891-17-000225 · edgar.xml · derivative · entry 9 Aklog Lishan · CIK 0001665074 · Director · Chairman and CEO · 10% owner HCFP/Capital Partners III LLC · CIK 0001665111 · 10% owner Pavilion Venture Partners LLC · CIK 0001665114 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 45,300 Underlying: Common Stock · 600 shares Expires 2022-01-29 F2 · price: The warrants were purchased at a weighted average price of approximately $1.2467 per warrant. These warrants were purchased in multiple transactions at prices ranging from $1.23 to $1.25, inclusive. The reporting person undertakes to provide PAVmed Inc., any security holder of PAVmed Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of warrants purchased at each separate price within the ranges set forth this footnote to this Form 4. Read SEC document |
| August 25, 2017 Filed Aug 29, 2017 22:34 UTC |
Aklog LishanDirector · Chairman and CEO · 10% owner
HCFP/Capital Partners III LLC10% owner
Pavilion Venture Partners LLC10% owner
|
PurchaseCommon Stock | 900 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001094891-17-000225 · edgar.xml · nonDerivative · entry 1 Aklog Lishan · CIK 0001665074 · Director · Chairman and CEO · 10% owner HCFP/Capital Partners III LLC · CIK 0001665111 · 10% owner Pavilion Venture Partners LLC · CIK 0001665114 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 58,877 F1 · price: The shares were purchased at a weighted average price of approximately $4.21416667 per share. These shares were purchased in multiple transactions at prices ranging from $4.14 to $4.50, inclusive. The reporting person undertakes to provide to PAVmed Inc., any security holder of PAVmed Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth this footnote to this Form 4. Read SEC document |
| August 24, 2017 Filed Aug 25, 2017 18:59 UTC |
Aklog LishanDirector · Chairman and CEO · 10% owner
HCFP/Capital Partners III LLC10% owner
Pavilion Venture Partners LLC10% owner
|
PurchaseCommon Stock | 1,200 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001094891-17-000221 · edgar.xml · nonDerivative · entry 2 Aklog Lishan · CIK 0001665074 · Director · Chairman and CEO · 10% owner HCFP/Capital Partners III LLC · CIK 0001665111 · 10% owner Pavilion Venture Partners LLC · CIK 0001665114 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 57,977 F2 · price: The shares were purchased at a weighted average price of approximately $4.23 per share. These shares were purchased in multiple transactions at prices ranging from $4.00 to $4.20, inclusive. The reporting person undertakes to provide to PAVmed Inc., any security holder of PAVmed Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth this footnote to this Form 4. Read SEC document |
| August 24, 2017 Filed Aug 28, 2017 11:14 UTC |
MCGRATH DENNIS MEVP & CFO
|
PurchaseCommon Stock | 1,000 | $4.24 | $4,242.90 |
DisclosureSEC source: 0001094891-17-000223 · edgar.xml · nonDerivative · entry 5 MCGRATH DENNIS M · CIK 0001269340 · EVP & CFO 10b5-1 filing: Not disclosed Ownership: Indirect · By MSSB C/F Dennis M. McGrath IRA Disclosed balance after: 12,000 Read SEC document |
| August 24, 2017 Filed Aug 28, 2017 11:14 UTC |
MCGRATH DENNIS MEVP & CFO
|
PurchaseCommon Stock | 500 | $4.24 | $2,121.00 |
DisclosureSEC source: 0001094891-17-000223 · edgar.xml · nonDerivative · entry 4 MCGRATH DENNIS M · CIK 0001269340 · EVP & CFO 10b5-1 filing: Not disclosed Ownership: Indirect · By MSSB C/F Dennis M. McGrath IRA Disclosed balance after: 11,000 Read SEC document |
| August 24, 2017 Filed Aug 28, 2017 11:14 UTC |
MCGRATH DENNIS MEVP & CFO
|
PurchaseCommon Stock | 500 | $4.24 | $2,119.95 |
DisclosureSEC source: 0001094891-17-000223 · edgar.xml · nonDerivative · entry 3 MCGRATH DENNIS M · CIK 0001269340 · EVP & CFO 10b5-1 filing: Not disclosed Ownership: Indirect · By MSSB C/F Dennis M. McGrath IRA Disclosed balance after: 10,500 Read SEC document |
| August 24, 2017 Filed Aug 28, 2017 11:14 UTC |
MCGRATH DENNIS MEVP & CFO
|
PurchaseCommon Stock | 500 | $4.19 | $2,094.00 |
DisclosureSEC source: 0001094891-17-000223 · edgar.xml · nonDerivative · entry 2 MCGRATH DENNIS M · CIK 0001269340 · EVP & CFO 10b5-1 filing: Not disclosed Ownership: Indirect · By MSSB C/F Dennis M. McGrath IRA Disclosed balance after: 10,000 Read SEC document |
| August 24, 2017 Filed Aug 28, 2017 11:14 UTC |
MCGRATH DENNIS MEVP & CFO
|
PurchaseCommon Stock | 500 | $4.17 | $2,087.15 |
DisclosureSEC source: 0001094891-17-000223 · edgar.xml · nonDerivative · entry 1 MCGRATH DENNIS M · CIK 0001269340 · EVP & CFO 10b5-1 filing: Not disclosed Ownership: Indirect · By MSSB C/F Dennis M. McGrath IRA Disclosed balance after: 9,500 Read SEC document |
| August 23, 2017 Filed Aug 24, 2017 11:05 UTC |
MCGRATH DENNIS MEVP & CFO
|
PurchaseCommon Stock | 500 | $4.18 | $2,089.40 |
DisclosureSEC source: 0001094891-17-000217 · edgar.xml · nonDerivative · entry 6 MCGRATH DENNIS M · CIK 0001269340 · EVP & CFO 10b5-1 filing: Not disclosed Ownership: Indirect · By MSSB C/F Dennis M. McGrath IRA Disclosed balance after: 9,000 Read SEC document |
| August 23, 2017 Filed Aug 24, 2017 11:05 UTC |
MCGRATH DENNIS MEVP & CFO
|
PurchaseCommon Stock | 500 | $4.17 | $2,085.00 |
DisclosureSEC source: 0001094891-17-000217 · edgar.xml · nonDerivative · entry 5 MCGRATH DENNIS M · CIK 0001269340 · EVP & CFO 10b5-1 filing: Not disclosed Ownership: Indirect · By MSSB C/F Dennis M. McGrath IRA Disclosed balance after: 8,500 Read SEC document |
| August 23, 2017 Filed Aug 24, 2017 11:05 UTC |
MCGRATH DENNIS MEVP & CFO
|
PurchaseCommon Stock | 500 | $4.15 | $2,074.80 |
DisclosureSEC source: 0001094891-17-000217 · edgar.xml · nonDerivative · entry 4 MCGRATH DENNIS M · CIK 0001269340 · EVP & CFO 10b5-1 filing: Not disclosed Ownership: Indirect · By MSSB C/F Dennis M. McGrath IRA Disclosed balance after: 8,000 Read SEC document |
| August 23, 2017 Filed Aug 24, 2017 11:05 UTC |
MCGRATH DENNIS MEVP & CFO
|
PurchaseCommon Stock | 500 | $4.12 | $2,061.70 |
DisclosureSEC source: 0001094891-17-000217 · edgar.xml · nonDerivative · entry 3 MCGRATH DENNIS M · CIK 0001269340 · EVP & CFO 10b5-1 filing: Not disclosed Ownership: Indirect · By MSSB C/F Dennis M. McGrath IRA Disclosed balance after: 7,500 Read SEC document |
| August 23, 2017 Filed Aug 24, 2017 11:05 UTC |
MCGRATH DENNIS MEVP & CFO
|
PurchaseCommon Stock | 500 | $4.12 | $2,059.20 |
DisclosureSEC source: 0001094891-17-000217 · edgar.xml · nonDerivative · entry 2 MCGRATH DENNIS M · CIK 0001269340 · EVP & CFO 10b5-1 filing: Not disclosed Ownership: Indirect · By MSSB C/F Dennis M. McGrath IRA Disclosed balance after: 7,000 Read SEC document |
| August 23, 2017 Filed Aug 24, 2017 11:05 UTC |
MCGRATH DENNIS MEVP & CFO
|
PurchaseCommon Stock | 500 | $3.90 | $1,952.00 |
DisclosureSEC source: 0001094891-17-000217 · edgar.xml · nonDerivative · entry 1 MCGRATH DENNIS M · CIK 0001269340 · EVP & CFO 10b5-1 filing: Not disclosed Ownership: Indirect · By MSSB C/F Dennis M. McGrath IRA Disclosed balance after: 6,500 Read SEC document |
| August 23, 2017 Filed Aug 25, 2017 18:59 UTC |
Aklog LishanDirector · Chairman and CEO · 10% owner
HCFP/Capital Partners III LLC10% owner
Pavilion Venture Partners LLC10% owner
|
PurchaseCommon Stock | 7,900 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001094891-17-000221 · edgar.xml · nonDerivative · entry 1 Aklog Lishan · CIK 0001665074 · Director · Chairman and CEO · 10% owner HCFP/Capital Partners III LLC · CIK 0001665111 · 10% owner Pavilion Venture Partners LLC · CIK 0001665114 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 56,777 F1 · price: The shares were purchased at a weighted average price of approximately $4.21 per share. These shares were purchased in multiple transactions at prices ranging from $3.75 to $4.25, inclusive. The reporting person undertakes to provide to PAVmed Inc., any security holder of PAVmed Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth this footnote to this Form 4. Read SEC document |
| August 22, 2017 Filed Aug 23, 2017 11:22 UTC |
MCGRATH DENNIS MEVP & CFO
|
PurchaseCommon Stock | 500 | $4.25 | $2,124.95 |
DisclosureSEC source: 0001094891-17-000215 · edgar.xml · nonDerivative · entry 11 MCGRATH DENNIS M · CIK 0001269340 · EVP & CFO 10b5-1 filing: Not disclosed Ownership: Indirect · By MSSB C/F Dennis M. McGrath IRA Disclosed balance after: 6,000 Read SEC document |
| August 22, 2017 Filed Aug 23, 2017 11:22 UTC |
MCGRATH DENNIS MEVP & CFO
|
PurchaseCommon Stock | 500 | $4.24 | $2,120.95 |
DisclosureSEC source: 0001094891-17-000215 · edgar.xml · nonDerivative · entry 10 MCGRATH DENNIS M · CIK 0001269340 · EVP & CFO 10b5-1 filing: Not disclosed Ownership: Indirect · By MSSB C/F Dennis M. McGrath IRA Disclosed balance after: 5,500 Read SEC document |
| August 22, 2017 Filed Aug 23, 2017 11:22 UTC |
MCGRATH DENNIS MEVP & CFO
|
PurchaseCommon Stock | 500 | $4.24 | $2,120.90 |
DisclosureSEC source: 0001094891-17-000215 · edgar.xml · nonDerivative · entry 9 MCGRATH DENNIS M · CIK 0001269340 · EVP & CFO 10b5-1 filing: Not disclosed Ownership: Indirect · By MSSB C/F Dennis M. McGrath IRA Disclosed balance after: 5,000 Read SEC document |
| August 22, 2017 Filed Aug 23, 2017 11:22 UTC |
MCGRATH DENNIS MEVP & CFO
|
PurchaseCommon Stock | 500 | $4.24 | $2,117.50 |
DisclosureSEC source: 0001094891-17-000215 · edgar.xml · nonDerivative · entry 8 MCGRATH DENNIS M · CIK 0001269340 · EVP & CFO 10b5-1 filing: Not disclosed Ownership: Indirect · By MSSB C/F Dennis M. McGrath IRA Disclosed balance after: 4,500 Read SEC document |
| August 22, 2017 Filed Aug 23, 2017 11:22 UTC |
MCGRATH DENNIS MEVP & CFO
|
PurchaseCommon Stock | 500 | $4.15 | $2,073.70 |
DisclosureSEC source: 0001094891-17-000215 · edgar.xml · nonDerivative · entry 7 MCGRATH DENNIS M · CIK 0001269340 · EVP & CFO 10b5-1 filing: Not disclosed Ownership: Indirect · By MSSB C/F Dennis M. McGrath IRA Disclosed balance after: 4,000 Read SEC document |
| August 22, 2017 Filed Aug 23, 2017 11:22 UTC |
MCGRATH DENNIS MEVP & CFO
|
PurchaseCommon Stock | 500 | $4.12 | $2,061.65 |
DisclosureSEC source: 0001094891-17-000215 · edgar.xml · nonDerivative · entry 6 MCGRATH DENNIS M · CIK 0001269340 · EVP & CFO 10b5-1 filing: Not disclosed Ownership: Indirect · By MSSB C/F Dennis M. McGrath IRA Disclosed balance after: 3,500 Read SEC document |
| August 22, 2017 Filed Aug 25, 2017 18:56 UTC |
Aklog LishanDirector · Chairman and CEO · 10% owner
HCFP/Capital Partners III LLC10% owner
Pavilion Venture Partners LLC10% owner
|
PurchaseCommon Stock | 1,500 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001094891-17-000219 · edgar.xml · nonDerivative · entry 2 Aklog Lishan · CIK 0001665074 · Director · Chairman and CEO · 10% owner HCFP/Capital Partners III LLC · CIK 0001665111 · 10% owner Pavilion Venture Partners LLC · CIK 0001665114 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 48,877 F2 · price: The shares were purchased at a weighted average price of approximately $4.18 per share. These shares were purchased in multiple transactions at prices ranging from $4.00 to $4.25, inclusive. The reporting person undertakes to provide to PAVmed Inc., any security holder of PAVmed Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth this footnote to this Form 4. Read SEC document |
| August 21, 2017 Filed Aug 23, 2017 11:22 UTC |
MCGRATH DENNIS MEVP & CFO
|
PurchaseCommon Stock | 500 | $4.24 | $2,120.85 |
DisclosureSEC source: 0001094891-17-000215 · edgar.xml · nonDerivative · entry 5 MCGRATH DENNIS M · CIK 0001269340 · EVP & CFO 10b5-1 filing: Not disclosed Ownership: Indirect · By MSSB C/F Dennis M. McGrath IRA Disclosed balance after: 3,000 Read SEC document |
| August 21, 2017 Filed Aug 23, 2017 11:22 UTC |
MCGRATH DENNIS MEVP & CFO
|
PurchaseCommon Stock | 1,000 | $4.24 | $4,241.40 |
DisclosureSEC source: 0001094891-17-000215 · edgar.xml · nonDerivative · entry 4 MCGRATH DENNIS M · CIK 0001269340 · EVP & CFO 10b5-1 filing: Not disclosed Ownership: Indirect · By MSSB C/F Dennis M. McGrath IRA Disclosed balance after: 2,500 Read SEC document |
| August 21, 2017 Filed Aug 23, 2017 11:22 UTC |
MCGRATH DENNIS MEVP & CFO
|
PurchaseCommon Stock | 500 | $4.22 | $2,112.45 |
DisclosureSEC source: 0001094891-17-000215 · edgar.xml · nonDerivative · entry 3 MCGRATH DENNIS M · CIK 0001269340 · EVP & CFO 10b5-1 filing: Not disclosed Ownership: Indirect · By MSSB C/F Dennis M. McGrath IRA Disclosed balance after: 1,500 Read SEC document |
| August 21, 2017 Filed Aug 23, 2017 11:22 UTC |
MCGRATH DENNIS MEVP & CFO
|
PurchaseCommon Stock | 500 | $4.22 | $2,108.90 |
DisclosureSEC source: 0001094891-17-000215 · edgar.xml · nonDerivative · entry 2 MCGRATH DENNIS M · CIK 0001269340 · EVP & CFO 10b5-1 filing: Not disclosed Ownership: Indirect · By MSSB C/F Dennis M. McGrath IRA Disclosed balance after: 1,000 Read SEC document |
| August 21, 2017 Filed Aug 23, 2017 11:22 UTC |
MCGRATH DENNIS MEVP & CFO
|
PurchaseCommon Stock | 500 | $4.09 | $2,046.05 |
DisclosureSEC source: 0001094891-17-000215 · edgar.xml · nonDerivative · entry 1 MCGRATH DENNIS M · CIK 0001269340 · EVP & CFO 10b5-1 filing: Not disclosed Ownership: Indirect · By MSSB C/F Dennis M. McGrath IRA Disclosed balance after: 500 Read SEC document |
| August 21, 2017 Filed Aug 25, 2017 18:56 UTC |
Aklog LishanDirector · Chairman and CEO · 10% owner
HCFP/Capital Partners III LLC10% owner
Pavilion Venture Partners LLC10% owner
|
PurchaseCommon Stock | 7,500 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001094891-17-000219 · edgar.xml · nonDerivative · entry 1 Aklog Lishan · CIK 0001665074 · Director · Chairman and CEO · 10% owner HCFP/Capital Partners III LLC · CIK 0001665111 · 10% owner Pavilion Venture Partners LLC · CIK 0001665114 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 47,377 F1 · price: The shares were purchased at a weighted average price of approximately $4.20 per share. These shares were purchased in multiple transactions at prices ranging from $4.00 to $4.25, inclusive. The reporting person undertakes to provide to PAVmed Inc., any security holder of PAVmed Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth this footnote to this Form 4. Read SEC document |
| August 18, 2017 Filed Aug 21, 2017 11:19 UTC |
Aklog LishanDirector · Chairman and CEO · 10% owner
HCFP/Capital Partners III LLC10% owner
Pavilion Venture Partners LLC10% owner
|
PurchaseWarrants · Derivative | 100 | $1.50 Strike: $5.00 | $149.99 |
DisclosureSEC source: 0001094891-17-000209 · edgar.xml · derivative · entry 11 Aklog Lishan · CIK 0001665074 · Director · Chairman and CEO · 10% owner HCFP/Capital Partners III LLC · CIK 0001665111 · 10% owner Pavilion Venture Partners LLC · CIK 0001665114 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 44,700 Underlying: Common Stock · 100 shares Expires 2022-01-29 Read SEC document |
| August 18, 2017 Filed Aug 21, 2017 11:19 UTC |
Aklog LishanDirector · Chairman and CEO · 10% owner
HCFP/Capital Partners III LLC10% owner
Pavilion Venture Partners LLC10% owner
|
PurchaseWarrants · Derivative | 100 | $1.42 Strike: $5.00 | $142.10 |
DisclosureSEC source: 0001094891-17-000209 · edgar.xml · derivative · entry 10 Aklog Lishan · CIK 0001665074 · Director · Chairman and CEO · 10% owner HCFP/Capital Partners III LLC · CIK 0001665111 · 10% owner Pavilion Venture Partners LLC · CIK 0001665114 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 44,600 Underlying: Common Stock · 100 shares Expires 2022-01-29 Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.